LIR Life Sciences Corp. (CSE:SKNY)

Canada · Delayed Price · Currency is CAD

0.2200

0.00 (0.00%)

Oct 6, 2026, 12:16 PM EST

LIR Life Sciences Financials Overview

Financials in millions CAD. Fiscal year is May - April.

Millions CAD. Fiscal year is May - Apr.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024
Period Ending	Jul '26 Jul 31, 2026	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024
Gross Profit	-0.01	-0.02	-	-
Operating Income	-4.28	-3.43	-0.42	-0.08
Net Income	-4.75	-3.9	-0.42	-0.08
Earnings Per Share	-0.18	-0.17	-0.08	-6.33
EPS Growth	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024
Period Ending	Jul '26 Jul 31, 2026	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024
Cash & Investments	0.2	0.6	0.12	0.2
Total Debt	-	-	-	0.19
Net Cash (Debt)	0.2	0.6	0.12	0
Net Cash Growth	-	393.49%	147336.58%	-
Net Cash Per Share	0.01	0.03	0.02	0.01

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024
Period Ending	Jul '26 Jul 31, 2026	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024
Operating Cash Flow	-2.39	-2.04	-0.25	0
Free Cash Flow	-2.39	-2.04	-0.25	0
Free Cash Flow Growth	-	-	-	-

Valuation

Selected indicators aren't available for this stock.